Interactive Virtual Assistance for Self-Care Management and Mental Health Promotion in Type 2 Diabetes
NCT ID: NCT05329376
Last Updated: 2024-05-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
112 participants
INTERVENTIONAL
2023-06-20
2024-05-17
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
OBJECTIVES: This project aims to evaluate the effectiveness of using an interactive virtual assistance system in mental health parameters, glycemic profile and diabetes selfcare behavior in elderly people with diabetes.
METHODS: A randomized clinical trial is proposed, for an intervention that includes 3 months of use of the Smart Speaker Echo Dot system, programmed to provide reminders, stimulate treatment records and maintain healthy habits. Outcomes assessed will include parameters of mental health and diabetes control.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy and Safety of Voice Inception Technique Based U-healthcare Service in Patients With Type 2 Diabetes Mellitus
NCT01891474
Continuous Glucose Monitoring and Behavioral Change Intervention for People With Type 2 Diabetes and Diabetes Distress
NCT05941000
Ubiquitous Healthcare for Elderly Patients With Type 2 Diabetes Mellitus
NCT01137058
Enhancing Shared Decision-making to Guide Care for People With Dementia and Diabetes
NCT05643144
Effectiveness of Individualized Automatic Coaching Message for Glycemic Management and Depressive Symptom
NCT06769906
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group A
12 weeks of daily interactions with Smart Speaker EchoDot 3rd Gen (Amazon Echo®).
Smart Speaker Echo Dot
Participants will receive the Smart Speaker EchoDot 3rd Gen (Amazon Echo®) device (i.e., Alexa) for home use, installed during a home visit following the study enrollment. In addition to the usual functionality of the system, the device will be programmed using a standard model developed by the research team, applied to each patient. The proposed model involves automatic interactions between the device and the patient, comprising:
1. Medication reminders
2. Glucose test reminders:
3. Educational health tips
4. Weekly educational podcasts
5. Good morning and good night routine
Group B
12 weeks of maintenance of usual care.
Usual Care
Participants will maintain usual care during the study period and will receive a booklet with general advice following enrollment
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Smart Speaker Echo Dot
Participants will receive the Smart Speaker EchoDot 3rd Gen (Amazon Echo®) device (i.e., Alexa) for home use, installed during a home visit following the study enrollment. In addition to the usual functionality of the system, the device will be programmed using a standard model developed by the research team, applied to each patient. The proposed model involves automatic interactions between the device and the patient, comprising:
1. Medication reminders
2. Glucose test reminders:
3. Educational health tips
4. Weekly educational podcasts
5. Good morning and good night routine
Usual Care
Participants will maintain usual care during the study period and will receive a booklet with general advice following enrollment
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Having a diagnosis of type 2 diabetes;
* Residing in Porto Alegre or metropolitan region;
* Presenting availability of Wi-Fi connection at home; and
* Presenting availability to participate in the proposed face-to-face evaluation and accept receiving one visit for installation of the device.
Exclusion:
* Having an interactive virtual home assistance device at the time of enrollment;
* Having cognitive impairments or severe hearing impairments that prevent adequate interaction with outcome assessors and the application of follow-up questionnaires; or
* Residing in regions of difficult access.
Recruitment:
Study subjects will be recruited through two different strategies:
* Screening of records of the outpatients clinics of Hospital São Lucas (HSL)
* Social media advertising, specially in Instagram®
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Pontificia Universidade Católica do Rio Grande do Sul
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Pontifícia Universidade Católica do Rio Grande do Sul
Porto Alegre, Rio Grande do Sul, Brazil
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
da Costa FL, Matzenbacher LS, Gheno V, Brum MAB, de Barros LGB, Maia IS, Blank LM, Fontoura LF, Alessi J, Telo GH. Interactive virtual assistance for mental health promotion and self-care management in elderly with type 2 diabetes (IVAM-ED): study protocol and statistical analysis plan for a randomized controlled trial. Trials. 2024 Mar 21;25(1):205. doi: 10.1186/s13063-024-08055-3.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20220311
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.